|Cancer Genetics, Inc. Featured in Two Key Latin American Genetics Conferences|
Published studies support the use of FHACT™ as an aid in the screening of women with HPV-positive abnormal cervical lesions (http://goo.gl/RjitXd). FHACT™ ... These cancers include hematological, urogenital and HPV-associated cancers. We also offer a ...
GlobeNewswire (press release) - Thu, 21 Nov 2013 04:56
|Cancer Genetics, Inc. Announces US Launch of Its Proprietary DNA-Based ...|
The test will be made available to help in the triaging and decision-making associated with the roughly 3.5 million abnormal Pap smears in the U.S. each year in order to diagnose and manage cervical cancer. CGI's FHACT(TM) test provides genomic ...
Wall Street Journal - Mon, 18 Nov 2013 05:18
|Viagra Sildenafil, Tadalafil For Sale Generic|
Republica - Tue, 19 Nov 2013 04:45
|Cancer Genetics, Inc. Granted Patent for Kidney Cancer Diagnosis & Typing ...|
Using an algorithm developed by CGI, the analysis of these genomic abnormalities allows for an accurate diagnosis of the four main types of kidney cancers representing approximately 90% of all cases, and the ability to distinguish among benign and ...
Wall Street Journal - Wed, 06 Nov 2013 05:04
|Cancer Genetics Inc (CGIX): Cancer Genetics' CEO Discusses Q3 2013 Results ...|
First and foremost would genomics-based diagnostics company focused on delivering unique comprehensive insights of our blood-borne and urogenital cancers that help in the personalization of cancer treatment. ... later this month on the approval and ...
Seeking Alpha - Wed, 13 Nov 2013 23:29